Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Ariella, Zivelin"'
Autor:
Michal Zucker, Ariella Zivelin, Meytal Landau, Ophira Salomon, Gili Kenet, Frederic Bauduer, Michel Samama, Jacqueline Conard, Marie-Hélène Denninger, Abu-Samra Hani, Micheline Berruyer, Donald Feinstein, Uri Seligsohn
Publikováno v:
Haematologica, Vol 92, Iss 10 (2007)
Background and Objectives Factor XI (FXI) deficiency is a rare autosomal recessive disorder, the main manifestation of which is injury-related bleeding. The disorder is rare in most populations, but common among Jews in whom two mutations, E117X and
Externí odkaz:
https://doaj.org/article/47f3ce0a707347499acff32ff6842104
Autor:
Uri Seligsohn, Avigal Lask, Amihai Rottenstreich, Yosef Kalish, Ariella Zivelin, Lilliana Schliamser
Publikováno v:
Journal of Thrombosis and Thrombolysis. 42:261-266
Inherited afibrinogenemia and hypofibrinogenemia are rare bleeding disorders characterized by markedly reduced levels of fibrinogen in blood. Thrombotic complications in these disorders have been rarely described. We performed a multicenter retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::992d3e59327913bd4eb3f23320484dc5
https://doi.org/10.1007/s11239-015-1325-0
https://doi.org/10.1007/s11239-015-1325-0
Autor:
Ophira Salomon, Uri Martinowitz, Ivan Budnik, Boris Shenkman, Rachel Mansharov, Rima Dardik, Tami Livnat, Ilia Tamarin, Ariella Zivelin
Publikováno v:
Thrombosis Research. 136:465-473
The phenotype of bleeding in patients with severe FXI deficiency is unpredictable and unlike other bleeding disorders, it is not directly correlated with levels of FXI. In this study we analyzed whether the global coagulation assays can serve as a cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b0ae55ad5f6eb205027fe400b47b21b
https://doi.org/10.1016/j.thromres.2015.06.025
https://doi.org/10.1016/j.thromres.2015.06.025
Autor:
Gili Kenet, Aharon Lubetsky, Tami Livnat, Tami Brutman-Barazani, Shirley Azar-Avivi, Uriel Martinowitz, Ariella Zivelin
Publikováno v:
Haemophilia. 19:782-789
Summary Treatment of haemophilia A patients with inhibitors is challenging, and may require individually tailored regimens. Whereas low titre inhibitor patients may respond to high doses of factor VIII (FVIII), high-responding inhibitor patients rend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5733f0257bb3cd3d38ba1e585d5b046a
https://doi.org/10.1111/hae.12181
https://doi.org/10.1111/hae.12181
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 1(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1ce309a84374353463fbb383e46ba6c
https://pubmed.ncbi.nlm.nih.gov/27214532
https://pubmed.ncbi.nlm.nih.gov/27214532
Autor:
Boris Shenkman, Ariella Zivelin, Samuel Gillis, Kenji Iijima, Ophira Salomon, Ilia Tamarin, David Varon, Tami Livnat, Gili Kenet
Publikováno v:
Blood Coagulation & Fibrinolysis. 22:673-679
Factor X (FX) is one of the vitamin K-dependent serine proteases, which forms the prothrombinase complex converting prothrombin into thrombin. To search for mutations in F10 gene giving rise to severe FX deficiency and to study the contribution of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae14ce060565c730be872d7c98791213
https://doi.org/10.1097/mbc.0b013e32834ad785
https://doi.org/10.1097/mbc.0b013e32834ad785
Autor:
Hava Peretz, Nurit Rosenberg, Uri Seligsohn, F. Bauduer, Ariella Zivelin, David Green, M. Zucker
Publikováno v:
Journal of Thrombosis and Haemostasis. 9:1977-1984
See also Duga S, Asselta R. Mutations in disguise. This issue, pp 1973–6. Summary. Background: Point mutations within exons are frequently defined as missense mutations. In the factor (F)XI gene, three point mutations, c.616C>T in exon 7, c.1060G>A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4092fc1309ef3c1cb66cc4b32324c27
https://doi.org/10.1111/j.1538-7836.2011.04426.x
https://doi.org/10.1111/j.1538-7836.2011.04426.x
Autor:
David M. Steinberg, David Varon, Uri Seligsohn, Ariella Zivelin, Ophira Salomon, Michal Zucker
Publikováno v:
Thrombosis and Haemostasis. 105:269-273
SummaryFactor XI (FXI) plays a dual role in haemostasis and thrombosis. It contributes to thrombin generation and promotes inhibition of fibrinolysis. Severe FXI deficiency was shown to confer protection against arterial and venous thrombosis in anim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5865684ba38697631a362f96d4321239
https://doi.org/10.1160/th10-05-0307
https://doi.org/10.1160/th10-05-0307
Autor:
Deborah Rubin-Asher, Ilan Asher, G Zeilig, Uri Seligsohn, Aaron Lubetsky, Aba Ratner, Ariella Zivelin
Publikováno v:
Thrombosis Research. 125:501-504
Venous thromboembolism (VTE) is a well-recognized complication of Acute Traumatic Spinal Cord Injury (ATSCI). Despite prophylaxis by heparins, VTE occurs in a substantial number of ATSCI patients without an obvious explanation. In this matched case-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c711e6aa506b5f62038dc42600d7f399
https://doi.org/10.1016/j.thromres.2009.09.012
https://doi.org/10.1016/j.thromres.2009.09.012
Publikováno v:
Blood Coagulation & Fibrinolysis. 20:661-666
Bleeding is a rare manifestation of antiphospholipid syndrome, unless associated with reduced clotting factors or severe thrombocytopenia. Accurate assessment of the autoantibodies in plasma is very important since the autoantibodies can lead to blee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53c5848322f366c2eef9dac8fbf45307
https://doi.org/10.1097/mbc.0b013e32832ff595
https://doi.org/10.1097/mbc.0b013e32832ff595